Hot Features
プレミアム
Corcept Therapeutics Inc (1CORT)
BIT
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-06-02 | Dr. William GuyerChief Development Officer | -20.00k | 979.00k | Derivative Exercise and Sale | 21.65 - 70.60 | 3.99k | - |
| 2026-06-02 | Mr. Joseph Douglas LyonChief Technology & Accounting Officer | -269.00 | 18.95k | Sale to Issuer | 70.44 | 7.04k | -3.68% |
| 2026-06-02 | Mr. Sean MaduckPresident of Endocrinology | -452.00 | 31.84k | Sale to Issuer | 70.44 | 119.47k | -0.38% |
| 2026-06-01 | Mr. Sean MaduckPresident of Endocrinology | -25.00k | 1.55M | Derivative Exercise and Sale | 8.27 - 70.75 | 119.47k | - |
| 2026-06-02 | Mr. Atabak MokariCFO & Treasurer | -395.00 | 27.82k | Sale to Issuer | 70.44 | 16.13k | -2.39% |
| 2026-06-01 | Mr. Atabak MokariCFO & Treasurer | -40.00k | 2.03M | Derivative Exercise and Sale | 19.26 - 70.00 | 16.13k | - |
| 2026-06-02 | Mr. Gary Charles RobbChief Business Officer & Secretary | -358.00 | 25.22k | Sale to Issuer | 70.44 | 100.54k | -0.35% |
| 2026-06-01 | Dr. Joseph K. BelanoffCo-Founder, President, CEO & Director | -12.84k | 895.25k | Automatic Disposition | 69.74 | 2.87M | -0.45% |
| 2026-05-29 | Dr. Joseph K. BelanoffCo-Founder, President, CEO & Director | -300.00k | 0.00 | Other Disposition | - | 2.87M | -9.48% |
| 2026-05-27 | Mr. Joseph Douglas LyonChief Technology & Accounting Officer | -5.00k | 325.00k | 売り | 65.00 | 6.23k | -44.52% |
| 2026-05-27 | Mr. Sean MaduckPresident of Endocrinology | -75.00k | 4.30M | Derivative Exercise and Sale | 8.27 - 66.16 | 118.69k | - |
| 2026-05-27 | Mr. James N. WilsonIndependent Chairman | -901.07k | 0.00 | Other Disposition | - | 1.50M | -37.46% |
| 2026-05-13 | Mr. Gary Charles RobbChief Business Officer & Secretary | -5.30k | 0.00 | Other Disposition | - | 99.35k | -5.06% |
| 2026-05-05 | Dr. William GuyerChief Development Officer | -20.00k | 603.60k | Derivative Exercise and Sale | 21.65 - 51.83 | 2.23k | - |
| 2026-05-01 | Dr. Joseph K. BelanoffCo-Founder, President, CEO & Director | -40.00k | 2.00M | Automatic Disposition | 50.10 | 2.88M | -1.37% |
| 2026-04-22 | Mr. James N. WilsonIndependent Chairman | -2.00k | 0.00 | Other Disposition | - | 2.40M | -0.08% |
| 2026-04-07 | Dr. William GuyerChief Development Officer | -20.00k | 386.40k | Derivative Exercise and Sale | 21.65 - 40.97 | 2.23k | - |
| 2026-04-06 | Mr. James N. WilsonIndependent Chairman | -5.00k | 0.00 | Other Disposition | - | 2.40M | -0.21% |
| 2026-03-25 | Dr. Joseph K. BelanoffCo-Founder, President, CEO & Director | -26.20k | 1.31M | Automatic Disposition | 50.07 | 2.92M | -0.89% |
| 2026-03-20 | Mr. James N. WilsonIndependent Chairman | -4.00k | 0.00 | Other Disposition | - | 2.40M | -0.17% |
| 2026-03-20 | Dr. William GuyerChief Development Officer | -11.77k | 168.97k | Derivative Exercise and Sale | 21.65 - 36.01 | 2.23k | - |
| 2026-03-17 | Mr. George Leonard BakerIndependent Director | 100.00k | 3.31M | 買い | 33.00 - 33.56 | 5.55M | 1.83% |
| 2026-03-13 | Mr. James N. WilsonIndependent Chairman | -28.00k | 0.00 | Other Disposition | - | 2.41M | -1.15% |
| 2026-03-13 | Mr. David L. MahoneyIndependent Director | -30.00k | 28.35 | Derivative Exercise and Sale | 5.86 - 32.15 | 1.28M | - |
| 2026-03-04 | Dr. William GuyerChief Development Officer | -8.23k | 118.10k | Derivative Exercise and Sale | 21.65 - 35.99 | 2.23k | - |
| 2026-03-03 | Mr. Joseph Douglas LyonChief Technology & Accounting Officer | -89.00 | 3.20k | Sale to Issuer | 35.97 | 11.23k | -0.79% |
| 2026-03-03 | Mr. Sean MaduckPresident of Endocrinology | -110.00 | 3.96k | Sale to Issuer | 35.97 | 118.69k | -0.09% |
| 2026-03-03 | Mr. Gary Charles RobbChief Business Officer & Secretary | -121.00 | 4.35k | Sale to Issuer | 35.97 | 102.65k | -0.12% |
| 2026-03-03 | Mr. Atabak MokariCFO & Treasurer | -96.00 | 3.45k | Sale to Issuer | 35.97 | 15.26k | -0.63% |
| 2026-02-24 | Mr. James N. WilsonIndependent Chairman | -100.00k | 1.28 | Derivative Exercise and Sale | 3.88 - 36.48 | 2.44M | - |
| 2026-01-08 | Mr. Sean MaduckPresident of Endocrinology | -54.57k | 0.00 | Other Disposition | - | 117.90k | -31.64% |
| 2026-02-09 | Dr. Hazel HuntChief Scientific Officer | 72.03k | 279.48k | Derivative Exercise and Retained Stock | 3.88 | 255.44k | 39.27% |
| 2026-02-09 | Dr. Hazel HuntChief Scientific Officer | -77.97k | 2.92M | Derivative Exercise and Sale | 3.88 - 41.31 | 255.44k | - |
| 2026-02-03 | Dr. William GuyerChief Development Officer | -20.00k | 384.33k | Derivative Exercise and Sale | 21.65 - 40.87 | 1.24k | - |
| 2026-01-27 | Mr. George Leonard BakerIndependent Director | 140.00k | 1.61M | Derivative Exercise and Retained Stock | 5.86 - 15.15 | 5.45M | 2.64% |
| 2026-01-06 | Dr. William GuyerChief Development Officer | -20.00k | 270.66k | Derivative Exercise and Sale | 21.65 - 35.18 | 1.24k | - |
| 2026-01-01 | Mr. George Leonard BakerIndependent Director | 0.00 | 0.00 | Other Disposition | - | 5.31M | 0.00% |
| 2025-12-24 | Mr. Gary Charles RobbChief Business Officer & Secretary | 64.72k | 251.10k | Derivative Exercise and Retained Stock | 3.88 | 101.77k | 174.66% |
| 2025-12-24 | Mr. Gary Charles RobbChief Business Officer & Secretary | -80.28k | 6.40M | Derivative Exercise and Sale | 3.88 - 83.59 | 101.77k | - |
| 2025-12-24 | Dr. Joseph K. BelanoffCo-Founder, President, CEO & Director | -550.00k | 23.52M | Derivative Exercise and Sale | 3.88 - 83.59 | 2.94M | - |
| 2025-12-12 | Mr. James N. WilsonIndependent Chairman | -400.00k | 0.00 | Other Disposition | - | 2.35M | -14.57% |
| 2025-12-02 | Dr. William GuyerChief Development Officer | -20.00k | 1.17M | Derivative Exercise and Sale | 21.65 - 80.88 | 1.24k | - |
| 2025-12-02 | Dr. William GuyerChief Development Officer | -787.00 | 0.00 | Other Disposition | - | 1.24k | -38.92% |
| 2025-12-01 | Mr. Sean MaduckPresident of Endocrinology | -20.00k | 1.43M | Derivative Exercise and Sale | 8.27 - 79.52 | 117.90k | - |
| 2025-12-02 | Mr. Sean MaduckPresident of Endocrinology | -135.00 | 10.77k | Sale to Issuer | 79.78 | 117.90k | -0.11% |
| 2025-12-01 | Mr. Joseph Douglas LyonChief Technology & Accounting Officer | -5.00k | 329.83k | Derivative Exercise and Sale | 13.56 - 79.53 | 10.52k | - |
| 2025-12-02 | Mr. Joseph Douglas LyonChief Technology & Accounting Officer | -110.00 | 8.78k | Sale to Issuer | 79.78 | 10.52k | -1.03% |
| 2025-12-02 | Mr. Atabak MokariCFO & Treasurer | -118.00 | 9.41k | Sale to Issuer | 79.78 | 14.56k | -0.80% |
| 2025-12-02 | Mr. Gary Charles RobbChief Business Officer & Secretary | -148.00 | 11.81k | Sale to Issuer | 79.78 | 37.05k | -0.40% |
| 2025-12-01 | Dr. Joseph K. BelanoffCo-Founder, President, CEO & Director | -40.00k | 3.19M | Automatic Disposition | 79.77 | 2.70M | -1.46% |
| 2025-11-25 | Dr. William GuyerChief Development Officer | -4.50k | 364.07k | 売り | 80.90 | 787.00 | -85.11% |
| 2025-11-17 | Dr. William GuyerChief Development Officer | -5.29k | 0.00 | Other Disposition | - | 787.00 | -87.04% |
| 2025-11-05 | Dr. William GuyerChief Development Officer | -20.00k | 1.07M | Derivative Exercise and Sale | 21.65 - 76.28 | 5.29k | - |
| 2025-11-03 | Mr. Joseph Douglas LyonChief Technology & Accounting Officer | -5.00k | 300.44k | Derivative Exercise and Sale | 13.56 - 73.65 | 10.28k | - |
| 2025-11-03 | Dr. Joseph K. BelanoffCo-Founder, President, CEO & Director | -40.00k | 2.98M | Automatic Disposition | 74.08 - 75.98 | 2.74M | -1.44% |
| 2025-11-03 | Mr. Sean MaduckPresident of Endocrinology | -20.00k | 1.31M | Derivative Exercise and Sale | 8.27 - 73.99 | 117.62k | - |
| 2025-10-10 | Mr. Daniel N. SwisherIndependent Director | -2.20k | 161.61k | Derivative Exercise and Sale | 14.08 - 87.54 | 0.00 | - |
| 2025-10-07 | Dr. William GuyerChief Development Officer | -20.00k | 1.37M | Derivative Exercise and Sale | 21.65 - 89.94 | 5.29k | - |
| 2025-10-01 | Dr. Joseph K. BelanoffCo-Founder, President, CEO & Director | -40.00k | 3.40M | Automatic Disposition | 84.29 - 85.67 | 2.78M | -1.42% |
| 2025-10-01 | Mr. Joseph Douglas LyonChief Technology & Accounting Officer | -5.00k | 355.97k | Derivative Exercise and Sale | 13.56 - 85.39 | 10.28k | - |
| 2025-10-01 | Mr. Sean MaduckPresident of Endocrinology | -20.00k | 1.54M | Derivative Exercise and Sale | 5.05 - 85.58 | 117.62k | - |
| 2025-09-19 | Dr. William GuyerChief Development Officer | -200.00 | 0.00 | Other Disposition | - | 5.29k | -3.64% |
| 2025-09-10 | Dr. Gillian M. Cannonインサイダー | -7.39k | 0.00 | Other Disposition | - | 0.00 | -100.00% |
| 2025-09-10 | Mr. Daniel N. SwisherIndependent Director | -2.20k | 128.41k | Derivative Exercise and Sale | 14.08 - 72.45 | 0.00 | - |
| 2025-09-04 | Dr. Gillian M. Cannonインサイダー | 7.39k | 169.97k | Derivative Exercise and Retained Stock | 22.99 | 7.39k | - |
| 2025-09-04 | Dr. Gillian M. Cannonインサイダー | -3.61k | 170.03k | Derivative Exercise and Sale | 22.99 - 70.13 | 7.39k | - |
| 2025-09-02 | Dr. William GuyerChief Development Officer | -20.00k | 976.85k | Derivative Exercise and Sale | 21.65 - 70.85 | 5.49k | - |
| 2025-09-02 | Mr. Joseph Douglas LyonChief Technology & Accounting Officer | -5.00k | 283.45k | Derivative Exercise and Sale | 13.56 - 70.76 | 10.28k | - |
| 2025-09-03 | Mr. Joseph Douglas LyonChief Technology & Accounting Officer | -189.00 | 13.49k | Sale to Issuer | 71.38 | 10.28k | -1.81% |
| 2025-09-02 | Mr. Sean MaduckPresident of Endocrinology | -20.00k | 1.31M | Derivative Exercise and Sale | 5.05 - 70.84 | 117.62k | - |
| 2025-09-03 | Mr. Sean MaduckPresident of Endocrinology | -233.00 | 16.63k | Sale to Issuer | 71.38 | 117.62k | -0.20% |
| 2025-09-02 | Dr. Joseph K. BelanoffCo-Founder, President, CEO & Director | -40.00k | 2.82M | Automatic Disposition | 70.52 - 71.01 | 2.82M | -1.40% |
| 2025-09-03 | Mr. Atabak MokariCFO & Treasurer | -144.00 | 10.28k | Sale to Issuer | 71.38 | 14.32k | -1.00% |
| 2025-09-03 | Mr. Gary Charles RobbChief Business Officer & Secretary | -256.00 | 18.27k | Sale to Issuer | 71.38 | 36.75k | -0.69% |
| 2025-08-22 | Mr. Gary Charles RobbChief Business Officer & Secretary | -5.00k | 336.68k | Derivative Exercise and Sale | 3.88 - 71.27 | 36.51k | - |
| 2025-08-11 | Mr. Daniel N. SwisherIndependent Director | -2.20k | 128.08k | Derivative Exercise and Sale | 14.08 - 72.30 | 0.00 | - |
| 2025-08-08 | Dr. William GuyerChief Development Officer | -35.01k | 1.75M | Derivative Exercise and Sale | 21.65 - 71.77 | 5.49k | - |
| 2025-08-05 | Dr. William GuyerChief Development Officer | -14.00 | 701.68 | Derivative Exercise and Sale | 21.65 - 71.77 | 5.49k | - |
| 2025-08-01 | Mr. Sean MaduckPresident of Endocrinology | -35.01k | 2.20M | Derivative Exercise and Sale | 5.05 - 69.70 | 117.40k | - |
| 2025-06-12 | Mr. Sean MaduckPresident of Endocrinology | -50.02k | 0.00 | Other Disposition | - | 117.40k | -29.88% |
| 2025-08-01 | Dr. Joseph K. BelanoffCo-Founder, President, CEO & Director | -40.00k | 2.74M | Automatic Disposition | 67.81 - 69.65 | 2.86M | -1.38% |
| 2025-08-01 | Mr. Joseph Douglas LyonChief Technology & Accounting Officer | -5.82k | 314.17k | Derivative Exercise and Sale | 13.56 - 67.51 | 10.07k | - |
| 2025-07-17 | Mr. Sean MaduckPresident of Endocrinology | -4.79k | 327.61k | Derivative Exercise and Sale | 5.05 - 73.48 | 117.40k | - |
| 2025-07-17 | Dr. William GuyerChief Development Officer | -4.88k | 252.86k | Derivative Exercise and Sale | 21.65 - 73.48 | 5.49k | - |
| 2025-07-17 | Mr. Joseph Douglas LyonChief Technology & Accounting Officer | -4.08k | 244.26k | Derivative Exercise and Sale | 13.56 - 73.48 | 10.07k | - |
| 2025-07-17 | Dr. Joseph K. BelanoffCo-Founder, President, CEO & Director | -615.00 | 45.32k | Automatic Disposition | 73.69 | 2.90M | -0.02% |
| 2025-07-10 | Mr. Daniel N. SwisherIndependent Director | -2.20k | 125.40k | Derivative Exercise and Sale | 14.08 - 71.08 | 0.00 | - |
| 2025-07-01 | Dr. William GuyerChief Development Officer | -100.00 | 5.19k | Derivative Exercise and Sale | 21.65 - 73.51 | 5.49k | - |
| 2025-07-01 | Mr. Joseph Douglas LyonChief Technology & Accounting Officer | -100.00 | 5.99k | Derivative Exercise and Sale | 13.56 - 73.51 | 10.07k | - |
| 2025-07-01 | Mr. Sean MaduckPresident of Endocrinology | -205.00 | 14.02k | Derivative Exercise and Sale | 5.05 - 73.45 | 117.40k | - |
| 2025-06-16 | Mr. Gary Charles RobbChief Business Officer & Secretary | -3.19k | 225.40k | 売り | 70.77 | 36.51k | -8.02% |
| 2025-06-10 | Mr. Daniel N. SwisherIndependent Director | -2.20k | 124.37k | Derivative Exercise and Sale | 14.08 - 70.61 | 0.00 | - |
| 2025-06-10 | Dr. William GuyerChief Development Officer | -20.00k | 1.02M | Derivative Exercise and Sale | 21.65 - 72.75 | 5.49k | - |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
